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Background: White matter hyperintensities may contribute to depression by disrupting neural connections among
brain regions that regulate mood. Orthostatic hypotension (OH) may be a risk factor for white matter
hyperintensities and accumulating evidence, although limited suggests it may play a role in the development of
late-life depression. The aim of this study was to examine the relationship between an oscillometric measure of
orthostatic hypotension and depression in population based sample of older adults.
Methods: We analysed data on adults aged 60 and over from the first wave of The Irish Longitudinal Study on
Ageing (TILDA). Depression was assessed using the Center for Epidemiologic Studies – Depression (CES–D) scale
and OH was assessed by a sit-to-stand orthostatic stress test; two seated blood pressure measurements were
followed by a single standing blood pressure measurement. Participants self reported whether they felt dizzy,
light-headed or unsteady on standing.
Results: Participants with symptomatic OH (SOH, n=20) had the highest mean CES-D score (mean 8.6, SE 1.6) when
compared to participants with asymptomatic OH (AOH) (mean 5.6, SE .48) and participants with no OH (mean 5.2,
SE .14) and this difference was significant for both comparisons (p<0.001). Linear regression analysis adjusted for
socio-demographic and clinical characteristics showed that SOH was associated with higher CES-D scores
(unstandardised B coefficient = 2.24; 95% CI .301 - 4.79; p =0.05) compared to participants without OH. AOH was
not associated with higher CES-D scores (unstandardised B coefficient =.162; 95% CI -.681, 1.00; p= 0.70).
Conclusions: Symptomatic orthostatic hypotension is associated with depression in older adults and needs to be
considered in studies examining the relationship between vascular disease and depression in older adults.Background
Depression is common in late life [1] and associated with
diverse aetiological factors that are poorly understood.
Evidence of an association between vascular disease and
late-life depression (LLD) led to the ‘vascular depression
hypothesis’ which proposed that structural damage to the
frontostriatal tracts resulting from ischemic cerebrovascu-
lar disease creates a vulnerability to depression in late life
[2,3]. This hypothesis stimulated much research and* Correspondence: oreganc1@tcd.ie
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reproduction in any medium, provided the orlaid the foundation for examining the mechanisms by
which vascular disease influences the development of
depression in older adults. As a result, a mechanistic
model for vascular depression has recently been proposed
that identifies hypoperfusion as a potential mechanistic
path to vascular depression [4].
Blood flow to the brain is influenced by systemic hemo-
dynamics and cerebrovascular autoregulation, whereby
cerebral arteries contract or dilate in response to arterial
blood pressure (BP) changes. These processes interact
to maintain stable perfusion but are impaired in the
context of vascular disease leading to perfusion deficits
and potentially the development of white matter hype-
rintensities (WMHs) [4]. White matter is sensitive toal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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arterioles with limited collateral flow and so is more
susceptible to minor changes in flow due to impaired
autoregulation and consequent infarction [5]. WMHs
are believed to contribute to the pathogenesis of LLD
since MRI studies have repeatedly found higher densities
in the frontal lobes [6-8] and basal ganglia [8] of older
people with major depression (MD) and these regions of
the brain are known to regulate mood and cognition.
Although the pathology of WMHs varies, autopsy studies
have shown that they are associated with ischemic damage
and tissue hypoxia in patients with late-life major depres-
sion [9]. In animal models white matter ischemia results
from drops in blood pressure [10] and a recent study [11]
has shown a relationship between the degree of orthostatic
drop in BP and WMH volume in LLD.
Hemodynamic homeostasis becomes less effective with
aging and is associated with a decreased ability to regulate
BP [12]. Orthostatic hypotension (OH) is an excessive fall
in BP after standing which may result from inadequate
intravascular volume, autonomic nervous system dysfunc-
tion, decreased venous return or an inability to increase
cardiac output in response to postural changes [13]. After
essential hypertension, OH is the most common disorder
of BP regulation and in adults aged 65 years and older the
prevalence ranges between 5 and 30%; depending on the
population studied and definition used [14]. Prospective
studies have shown that OH is predictive of ischemic
stroke [15] and all-cause mortality in older adults [16].
In 1996, a consensus committee defined classical OH
as a drop of at least 20 mmHg in systolic blood pressure
(SBP) or 10 mmHg in diastolic blood pressure (DBP)
within the first 3 minutes of standing [17]. This may
reduce perfusion pressure of organs, especially above
heart level, such as the brain. OH can be asymptomatic
or manifest as symptoms that range from dizziness and
light-headedness to weakness and loss of consciousness.
These symptoms arise from periods of hypoperfusion
that have the potential to induce ischemic damage and
WMHs [14,18]. For this reason, it has been suggested
that OH may play an important role in the development
of depression and accumulating evidence, although
limited shows that OH may be more frequent in late-
life depression [19,20]. Previous studies confirming an
association between OH and depression were conducted
on small clinical cohorts of patients with a formal diag-
nosis of MD and using hospital based digital photo-
plethysmographic measures of phasic BP. It is not
known whether the association would persist in the
general population; where lower prevalence and severity
rates for these conditions are observed, and using trad-
itional oscillometric measures of BP. Consequently, the
aim of this study is to investigate if OH is associated with
depression in a nationally representative sample of olderadults utilising a standard test of OH and a self-report
measure of depression.
Methods
Study design
We analysed data from the first wave of The Irish Longitu-
dinal Study on Ageing (TILDA) collected between October
2009 and February 2011. Full details of the sampling
procedure and response have been described elsewhere
[21]. In short TILDA is a study of community dwelling
adults (nationally representative sample) aged 50 and over.
Participants completed a computer-assisted personal inter-
view (CAPI) in their own homes which included detailed
questions on health, social and economic circumstances.
Each participant was then invited to a health centre for a
comprehensive health assessment. Participants who were
unable or unwilling to attend a health centre were offered
a modified assessment in their own home. People with
known or suspected dementias were ineligible at baseline
for participation. All assessments were carried out by
trained nurses. The study was approved by the Faculty
of Health Sciences Research Ethics Committee at Trinity
College Dublin and all participants gave informed written
consent. All experimental procedures adhered to the
Declaration of Helsinki. The measures specific to the
current analysis are described below.
Neuropsychiatric assessment
The primary outcome measure for this analysis was the
mean score on the 20-item Centre for Epidemiologic
Studies Depression scale (CES-D). The CES-D generates
a total score with a range between 0 and 60 with higher
scores indicating greater depressive symptoms. A cut-off
of 16 has been shown to have a sensitivity of 100% and a
specificity of 88% for MD in older adults [22,23]. LLD is
commonly defined as depression occurring in adults aged
60 or 65 years and over therefore only participant’s ≥ 60
years were included in the analysis. Participants taking
antidepressants were excluded from this study.
Anxiety was assessed using the Hospital Anxiety De-
pression Scale – Anxiety subscale. A cut-off of ≥11 was
used to classify participants with anxiety [24]. The MMSE
(Mini Mental State Examination) was used to assess
cognition [25].
Blood pressure measurement
Participants underwent a sit-to-stand orthostatic stress
test (STST).
Seated blood pressure
Two seated SBP and DBP measurements were obtained
1 minute apart using an OMRON™ digital automatic
blood pressure monitor (Model M10-IT). Participants had
been seated for at least 30 minutes and were a minimum
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was obtained. The means of the two sitting SBP and DBP
readings were used in the analysis.
Standing blood pressure
Immediately after the second seated BP measurement, the
participant was asked to stand and a single SBP and DBP
measurement was obtained, using the same monitor with
the cuff at heart level. Immediately after the standing BP
measurement was complete, participants were asked to
report whether they had felt dizzy, light-headed or unsteady
on standing (yes or no to any of the symptoms).
Asymptomatic orthostatic hypotension Participants
with a reduction of SBP of at least 20 mmHg or DBP of
10 mmHg without symptoms of dizziness/light-headedness
after standing were classified as having asymptomatic OH
(AOH).
Symptomatic orthostatic hypotension Participants with
a reduction of SBP of at least 20 mmHg or DBP of
10 mmHg accompanied by symptoms of dizziness/light-
headedness after standing were classified as having symp-
tomatic OH (SOH).Health asses
(n=3437, 7
Not taking
anti-depressants
(n=3198, 93%)
3,144 completed CES-D & BP measures  (9
Figure 1 TILDA sample used in current analysis.Other measures
Other measures recorded during the home interview
(CAPI) included age, gender, highest level of educational
attainment (primary, secondary or tertiary), current smoking
status, history of cardiovascular disease and medication
use. Medication use was determined by recording medica-
tion names from the medicine bottles in the participant’s
home during the CAPI interview. Medications were classi-
fied using the World Health Organization Anatomical
Therapeutic Chemical (ATC) system [26]. A dichotomous
variable for antihyperintensive medication was computed
(1=yes, 0=no) with the following ATC codes: C02; diuretic
drugs, C03; peripheral vasodilator drugs, C04; vasopro-
tective drugs, C05; β-blocking agents, C07; and calcium-
channel blockers C08. Psychotropic medications were
classified by ATC code N05. In addition to the beat-to-beat
BP measurements SBP and DBP were recorded during
seated rest using a digital automatic BP monitor (OMRON
Model M10-IT). For descriptive purposes, participants
were classified as hypertensive if the mean of their two
seated SBP measurements was ≥140 mmHg and/or if the
mean of their two seated DBP measurements was ≥90
mmHg or if they were currently taking antihypertensive
medications [27]. Objective measures of weight (1 measure
using SECA electronic floor scales) and height (1 measurePopulation sample 
≥50 years
(n=8,175)
Population sample 
≥60 years
(n=4,892, 60%)
sment
0%)
8%)
Taking 
anti-depressants
(n=239, 7%)
No health assessment
(n=1,455, 30%)
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to calculate body mass index (BMI). Total cholesterol was
determined from a venous blood sample.
Statistical analysis
Only participants who completed a health assessment were
eligible for inclusion. Statistical analysis was performed
using SPSS version 20. Distribution of continuous variables
was assessed using Q-Q plots and histograms. Normally
distributed variables were described as means and standard
errors (SE), and were compared using independent t-tests
and categorical variables were compared using Chi-squared
tests. AOH and SOH and were analysed separately a priori.
Multivariate linear regression analysis was used to
assess the relationship between OH and depression with
adjustment for potential confounders including age, sex,
education level, MMSE, history of cardiovascular disease
(angina, stroke, TIA, myocardial infarction), total choles-
terol, smoking (0=non/previous smoker, 1=current smoker),
BMI, SBP and DBP values, antihypertensive and psycho-
tropic medications as covariates. Unstandardised regression
coefficients, 95% confidence intervals and significance levels
are presented here. Differences with p<0.05 (two-tailed)Table 1 Demographic and clinical characteristics overall and
Overall
N=3144
Age mean (SE) 69.3 (.18) 69
Female sex n (%) 1650 52.0 15
Education: n (%)
Primary 1075 44.0 98
Secondary 1141 38.3 10
Tertiary 926 17.7 85
Current smoker n (%) 393 13.2 36
Hypertensiona n (%) 1830 59.5 16
Antihypertensive medications n (%) 1466 47.3 13
Psychotropic medication n (%) 193 6.1 18
History cardiovascular diseaseb n (%) 389 13.1 36
Diabetes n (%) 270 8.8 24
Anxietyc n (%) 150 5.7 13
Orthostatic symptomsd n (%) 20 8.5 0
High cholesterole mean (SE) 4.95 (.02) 4.
BMIf mean (SE) 27.7 (.05) 28
MMSEg mean (SE) 27.3 (.19) 28
amean of 2 seated systolic blood pressures is ≥140 mmHg and/or mean of 2 seated
antihypertensive medications.
bhistory of angina, stroke or myocardial infarction.
cHospital Anxiety and Depression Scale ≥ 11 (range 0–21).
dsymptoms of dizziness, lightheaded or unsteadiness on standing.
emeasure obtained from venous sample.
fBody Mass Index.
gMini Mental State Examination (range 0–30).
hcomparison of no OH and OH group based on t-test for continuous variables andwere considered statistically significant. Sensitivity analysis
was conducted to explore the impact of including partici-
pants on antidepressant medications. Data was weighted
with respect to age, sex and education to the Quarterly
National Household Survey (2010) and further weighted
to account for those who did not attend for a health assess-
ment (see TILDA wave 1 report for further information on
the calculation of weights, [www.tilda.ie]).
Results
Characteristics of the sample
At baseline 8,175 participants were recruited to the TILDA
study and the household response rate was 62%. 4,892
individuals were aged 60 and over and 3,437 of these
completed a health assessment. The study population
used in this analysis is depicted in Figure 1. In total
3,144 participants were eligible for the current analyses.
Of these, 52% were female with a mean age of 70.0,
(SE .01, range 60–98).
Table 1 shows demographic and clinical characteristics
of participants by orthostatic blood pressure group. 8%
(n=240) of participants in our study had OH and 9%
(n= 20) of these reported symptoms of dizziness, light-by OH group
No OH OH
P-valuehN=2904 N=240
.1 (.17) 71.6 (.59) t= −4.29 <0.001
06 51.2 144 61.8 X2= 5.89 0.01
8 43.6 87 49.2 X2= .489 0.48
62 38.6 79 33.5 X2= 1.29 0.26
2 17.7 74 17.4 X2= .232 0.65
0 13.1 33 14.4 X2= .371 0.54
67 58.7 163 69.4 X2= 10.5 0.002
24 46.7 122 54.3 X2= 3.14 0.08
1 6.2 12 5.0 X2=585 0.44
8 13.4 21 9.6 X2= 3.14 0.08
9 8.7 21 9.5 X2=.009 0.90
8 5.6 12 5.9 X2= .036 0.87
0 20 8.5 X2=243 <0.001
95 (.07) 4.99 (.07) t= −.627 0.53
.7 (.09) 27.8 (.19) t=2.35 0.01
.0 (.19) 27.2 (.88) t=2.12 0.04
diastolic blood pressures is ≥90 mmHg or currently taking
X2 for categorical variables.
Figure 2 Mean change in systolic/diastolic blood pressure
on standing.
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only reported by people who were classified with OH. Par-
ticipants with OH were more likely to be female (p=0.01),
had significantly more hypertension (p<0.001), lower BMI
(p=0.01) and a lower MMSE score (p=0.04).
OH and depression
Table 2 shows BP measurements in participants with
AOH and symptomatic SOH. Participants with SOH had
greater drops in SBP and DBP compared to participants
with AOH (see Figure 2). Figure 3 shows mean CES-D
score by OH group. Participants with SOH had the
highest mean CES-D score (mean 8.6, SE 1.6) when
compared to participants with AOH (mean 5.6, SE .48)
and participants without OH (mean 5.2, SE .14). In
multivariate linear regression analysis adjusted for socio-
demographic and clinical characteristics, SOH was associ-
ated with higher levels of depressive symptoms (seeTable 3).
Mean CES-D score was on average 3 points higher in
participants with SOH compared to participants without
OH. AOH was not associated with significantly higher
CES-D scores. Sensitivity analysis including participants
on antidepressants attenuated but did not eliminate the
significant association between SOH and depression
(unstandardised B coefficient = 1.4, 95% CI .11-3.9).
The sensitivity model included all covariates from model 3
and additionally controlled for antidepressant use.
Discussion
In this study, we found evidence of a relationship between
orthostatic hypotension and depression in participants with
OH who reported symptoms of hypoperfusion on standing.
Emerging evidence suggests that hypoperfusion may be
an important factor in the development of late-life vascular
depression [4]. OH can lead to cerebral auto-dysregulation
[28] which can impair cerebral blood flow (CBF) [29].
Perfusion deficits do not need to cause ischemia in order
to influence brain function. Mild CBF reduction impairs
protein synthesis [30] that is crucial for cognitive andTable 2 Blood pressure parameters by OH group
Asymptomatic OH
N=220
Mean SE
Seated systolic BPa 150.8 (1.4)
Seated diastolic BPa 86.8 (.80)
Standing systolic BP 129.5 (1.5)
Standing diastolic BP 79.50 (.85)
Mean change in SBPb −21.30 (.78)
Mean change in DBPc −7.30 (.63)
aaverage of 2 readings.
bmean of 2 seated SBP readings subtracted from 1 standing SBP reading.
cmean of 2 seated DBP readings subtracted from 1 standing DBP reading.affective processing while greater CBF reduction in the
context of autoregulatory deficits may cause ischemic
injury and WMHs [4]. Previous results linking OH and
depression have been observed among clinical samples
[11,19,20] where cases of OH and depression are respect-
ively more prevalent and severe. Our findings suggest that
in a representative sample of community dwelling older
adults, the relationship is limited to those with more severe
OH; since the association is dependent on the presence of
symptoms of hypoperfusion.
9% of participants with OH reported symptoms of dizzi-
ness/light-headedness on standing. Cerebral autoregulation
(CA) explains why OH does not produce symptoms in
all adults. Under normal physiologic conditions, changes
in mean arterial BP between 60 and 160 mmHg produce
little or no change in CBF. Beyond these limits, a sud-
den decrease in CBF occurs at the lower limit of auto-
regulation and likely manifests as orthostatic symptomsSymptomatic OH
N= 20
Mean SE t-test
146.8 (4.1) t=.996 p=0.320
87.4 (2.8) t=−.073 p=.942
121.1 (4.0) t=−1.87 p=.062
77.15 (2.1) t=−1.53 p=.127
−25.65 (.23) t=−1.75 p=.080
−10.25 (.14) t=−1.89 p=.050
Figure 3 Mean CES-D score by OH group.
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believed to occur in approximately one in four patients
and cerebral hypoperfusion occurs in response to rela-
tively small changes in BP [29]. Participants in our study
with symptomatic OH may have impaired CA and more
extreme changes in CBF resulting in orthostatic symptoms.
In contrast, those with asymptomatic OH may have better
preserved autoregulation centrally and therefore no symp-
toms of hypoperfusion from reduced CBF, despite clinically
significant drops in BP during standing. While a causal
relationship between WMH and cerebral hypoperfusion
induced by OH has yet to be established, both animal
models and human studies suggest that this exists [31,32]
and future waves of TILDA will investigate if OH at
baseline predicts depression at follow up.
The prevalence of hypertension was higher in partici-
pants with OH which could have confounded results since
hypertension is a known risk factor for OH [33] and
WMHs [34]. However, hypertension was not associated
with increased CES-D score in univariate analysis and the
addition of systolic and diastolic BP levels to the model
only slightly attenuated the association between SOH and
depression. The use of antihypertensive medication
was also somewhat higher in the OH group; however, the
relationship between SOH and depression also persisted
even after adjusting for these medications in the finalTable 3 Linear regression analysis examining the effect of OH
Model 1b Mod
B coeffe 95% CI p B coe
Asymptomatic OHa 0.333 -.499-1.16 0.40 0.199
Symptomatic OHa 2.83 .173-5.48 0.03 2.71
acomparsion group is participants without OH (coefficient for AOH and SOH model
bunivariate analysis.
cadjusted for age, sex, education.
dadjusted for age, sex, education, MMSE, History CVD, blood cholesterol, smoking, B
and psychotropic medications, seated systolic BP and seated diastolic BP.
eunstandardised B coefficient.model. In healthy community-dwelling adults such as our
participants these drugs are associated with only low rates
of orthostatic hypotension [11,35] making them unlikely
to have influenced our findings.
Participants currently taking antidepressants were ex-
cluded from our analysis. There is no simple way to ‘adjust’
for anti-depressant use in our baseline data since the
model we are trying to estimate is essentially cyclical
(i.e. our hypothesis is that OH causes depression, but
we know depression results in anti-depressant use and
anti-depressant use can cause OH).
7% of our target population were currently taking anti-
depressants (see Figure 1). Sensitivity analysis including
participants on antidepressants (and controlling for anti-
depressants in the model) attenuated but did not eliminate
the significant association between SOH and depression
and overlapping confidences intervals between estimates
derived from the sample with antidepressant users, and
without them, suggests no significant difference between
estimates .
The STST is commonly used in everyday clinical prac-
tice, however it is believed to have inferior sensitivity for
detecting OH compared to other orthostatic stress tests
(Active Stand Test or the Head-Up Tilt-Table Test) [36].
Automated BP machines can take 25–40 seconds to record
a measurement. We therefore expect that our findings
underestimate the prevalence of OH (compared with
prevalence rates estimated from phasic BP measurement)
and potentially any associations uncovered; given that
in some participants BP may have recovered before the
recording was completed. Interestingly, orthostatic symp-
toms were only reported by participants with OH which
would suggest that the STST has good sensitivity for
detecting those with severe OH. Previous studies linking
OH and depression have utilised continuous, beat-to-beat
BP monitoring to measure OH in patients with MD at
centre based assessments. Home respondents are known
to differ markedly from the centre based attendees and
in a TILDA pilot study we showed that participants who
selected a home assessment had poorer physical health
with higher levels depressive symptomology [37]. The
STST is easily administered in an individual’s home there-
fore it maximised the participation of older participants inon CES-D score
el 2c Model 3d
ff 95% CI p B coeff 95% CI p
-.624-1.02 0.635 0.162 -.681-1.00 0.70
.091-5.33 0.042 2.24 .301- 4.79 0.05
ed concurrently).
MI, heart.
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between symptomatic OH and depression.
The main strengths of this study are the large population
representative sample and comprehensive health assess-
ment. Limitations are that the data was analysed cross-
sectionally so we cannot make any direct inferences
about temporality. Although many relevant risk factors
were assessed and statistically controlled for in the analysis,
the possibility of residual confounding exists. In particular
psychotrophic medications are captured by a single vari-
able which could pool agents that cause OH with those
that do not. Depression was not formally diagnosed in
our study although the CES-D instrument is a well vali-
dated measure of depressive symptomatology [22,23].
The prevalence of MD in community samples of older
adults ranges from 1-5%, with the majority of studies
reporting prevalence in the lower end of the range
[38-41]. It is therefore likely that the CES-D overestimated
the prevalence of MD and our measure of depression rep-
resents both major and subthreshold depression. Another
limitation is that our primary conclusions were drawn
from the SOH group which only included 20 individuals;
the potential for spurious findings therefore exists. It must
also be acknowledged that in some participant’s vestibular
dizziness rather than hypotension could have caused
the symptoms of dizziness although in our study all
participants who reported symptoms had a clinically
significant drop in blood pressure. Moreover, dizziness
may also be a feature of anxiety which is highly co-morbid
with depression in this age group [42].Conclusion
In summary, we have identified an association between
symptomatic OH and depression in a large community-
based sample of older adults. Symptomatic orthostatic
hypotension may be an important, but not widely
recognised, risk factor for late-life depression which needs
to be considered in studies examining the relationship
between vascular disease and depression. Clinically, our
results are important as they show that the relationship
between SOH and depression is not limited to clinical
samples but extends to the general population and poten-
tially individuals with subthreshold depression. Clearly
longitudinal studies are required to clarify the direction of
this association.
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